1st Circ. To Review Crucial Issue In Teva, Regeneron Cases
By Yeji Jesse Lee · November 17, 2023, 9:15 PM EST
The First Circuit on Friday granted Teva Pharmaceutical's request to settle how rigorous the causation standard should be in federal False Claims Act kickback cases, a legal issue that has previously...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login